Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Jefferies John 2. Date of Event Requiring Statement (Month/Day/Year) 09/30/2025 3. Issuer Name and Ticker or Trading Symbol DAXOR CORP [DXR] (Last) (First) (Middle) 109 MECO LANE 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Medical Officer 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) OAK RIDGE, TN 37830 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Daxor Common Stock 15,272 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(1)	04/30/2028	Common Stock	885	$11.3	D
Stock Options (right to buy)	(2)	12/01/2027	Common Stock	14,660	$9.55	D
Stock Options (right to buy)	(1)	11/30/2027	Common Stock	539	$9.51	D
Stock Options (right to buy)	(1)	10/31/2027	Common Stock	283	$13.25	D
Stock Options (right to buy)	(1)	09/30/2027	Common Stock	236	$13.25	D
Stock Options (right to buy)	(1)	08/31/2027	Common Stock	309	$13.74	D
Stock Options (right to buy)	(1)	07/31/2027	Common Stock	448	$13.96	D
Stock Options (right to buy)	(1)	06/30/2027	Common Stock	284	$13.2	D
Stock Options (right to buy)	(1)	05/31/2027	Common Stock	406	$12.63	D
Stock Options (right to buy)	(1)	04/30/2027	Common Stock	327	$11.48	D
Stock Options (right to buy)	(1)	03/31/2027	Common Stock	364	$10.65	D
Stock Options (right to buy)	(1)	02/28/2027	Common Stock	469	$10.65	D
Stock Options (right to buy)	(1)	01/31/2027	Common Stock	380	$10.53	D
Stock Options (right to buy)	(1)	12/31/2026	Common Stock	199	$11.29	D
Stock Options (right to buy)	(1)	11/30/2026	Common Stock	216	$11	D
Stock Options (right to buy)	(1)	10/31/2026	Common Stock	116	$10.81	D
Stock Options (right to buy)	(1)	09/30/2026	Common Stock	353	$11.68	D
Stock Options (right to buy)	(1)	08/31/2026	Common Stock	221	$9.6	D
Stock Options (right to buy)	(1)	07/31/2026	Common Stock	275	$9.09	D
Stock Options (right to buy)	(1)	06/30/2026	Common Stock	224	$10.6	D
Stock Options (right to buy)	(1)	05/31/2026	Common Stock	147	$9.35	D
Stock Options (right to buy)	(1)	04/30/2026	Common Stock	129	$9.72	D
Stock Options (right to buy)	(1)	03/31/2026	Common Stock	145	$12.1	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Jefferies John 109 MECO LANE OAK RIDGE, TN 37830			Chief Medical Officer

Signatures

/s/ John Jefferies		09/30/2025
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	This option is presently exercisable in full.
(2)	The stock options will vest in three equal installments on December 1, 2023, December 1, 2024 and December 1, 2025.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.